NovoCure
NVCR · NASDAQ
Bulios Fair Price
$9.26
40.3% downside
Current Price
$15.51
According to Bulios Fair Price, NVCR is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
NovoCure Limited is an international biotechnology company specializing in the development of innovative therapies for cancer treatment. The company is known for its unique Tumor Treating Fields (TTFields) technology, which uses electric fields to target and treat tumors, inhibiting their growth. TTFields is a non-invasive treatment that is used for various types of cancer, including brain cancer, lung cancer, and more. NovoCure focuses on providing new therapeutic approaches that can improve treatment outcomes and the quality of life for patients suffering from cancer.
Sector
Healthcare
Industry
Medical - Devices
CEO
Frank Leonard
Employees
1,605
Headquarters
Baar
Upcoming events
Earnings
Upcoming earnings report